Home » today » Health » New Developments in Alzheimer’s Disease Treatment: A Focus on Risk Factors and Medications

New Developments in Alzheimer’s Disease Treatment: A Focus on Risk Factors and Medications

If there is a risk of Alzheimer’s disease.

Attention! Not a prescription

If there is a risk of Alzheimer’s disease, Dr. Myasnikov advises this:

– Attention! This is just information about the latest in medicine, not a prescription, the well-known doctor and TV presenter Alexander Myasnikov warned in his TG channel.

He shared the advanced developments of medicine in this direction. Below you will find out what we are talking about.

Doctor Myasnikov revealed

Dr. Myasnikov revealed that the basis of dementia is the deposition of a specific protein in the brain. The reasons are still not clear: these are genetics, and chronic microcirculation disorders in patients with atherosclerosis and hypertension, overweight and diabetes.

Among the risk factors are physical inactivity and, by the way, taking certain medications: benzodiazepines (sedatives), opioids and even antihistamines (anti-allergic), smoking, poor ecology.

What helps with dementia

Until now, the only drugs that have been tried to treat Alzheimer’s have been cholinesterase inhibitors and memantine (a complexly named antagonist of certain receptors).

– And now, for the first time since 2003, a new medicine has appeared. From the class of monoclonal antibodies (who are interested, read about this class of medicines) Aducarumab and Lekvembi, Alexander Myasnikov called them.

According to him, the action of the drug is directed against the formation of amyloid protein. He was not immediately admitted to the clinic due to unclear efficacy and a wide range of side effects. But now the 2nd phase of clinical trials has passed and recommendations for use have appeared with reservations.

2023-07-13 11:00:00

#Myasnikov #reveals #cure #dementia

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.